{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:56:24Z","timestamp":1790826984373,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Not available"],"award-info":[{"award-number":["Not available"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10072-026-09427-0","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:07:49Z","timestamp":1790824069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The close relationship between a rare disease and a common disease: Case report of a patient with gaucher disease and parkinsonism"],"prefix":"10.1007","volume":"47","author":[{"given":"Jos\u00e9 Lucas Gomes","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella Vieira Barroso","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi Miyazaki","family":"Fontoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saide Maria Sarmento","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Patr\u00edcia Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene Ilma Ribeiro","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Melo","family":"dos Santos Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Lopes","family":"dos Santos Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-6221","authenticated-orcid":false,"given":"Luiz Carlos","family":"Santana-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"9427_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1079-4","author":"MVMB Wilke","year":"2019","unstructured":"Wilke MVMB, Ribeiro LS, Cabral IB, Okada de Oliveira C, Silva ACS, de Souza CF et al (2019) Evaluation of the frequency of non-motor symptoms of Parkinson\u2019s disease in adult patients with Gaucher disease type 1. Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/s13023-019-1079-4","journal-title":"Orphanet J Rare Dis"},{"key":"9427_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1733970","author":"Y Chen","year":"2020","unstructured":"Chen Y, Sam R, Sharma S, Chen L, Xu Q, Li C et al (2020) Glucocerebrosidase as a therapeutic target for Parkinson\u2019s disease. Expert Opin Ther Targets. https:\/\/doi.org\/10.1080\/14728222.2020.1733970","journal-title":"Expert Opin Ther Targets"},{"key":"9427_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-00999-z","author":"E Hertz","year":"2024","unstructured":"Hertz E, Chen Y, Sidranky E (2024) Gaucher disease provides provides a unique window into Parkinson disease pathogenesis. Nat reviews Neurol. https:\/\/doi.org\/10.1038\/s41582-024-00999-z","journal-title":"Nat reviews Neurol"},{"key":"9427_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70190-4","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(12)70190-4","journal-title":"Lancet Neurol"},{"key":"9427_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-024-00812-2","author":"R Coukos","year":"2024","unstructured":"Coukos R, Krainc D (2024) Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/s41583-024-00812-2","journal-title":"Nat Rev Neurosci"},{"key":"9427_CR6","doi-asserted-by":"publisher","unstructured":"Santos-Lobato BL et al (2022) Lack of full sequencing GBA1 variants and Parkinson\u2019s disease in Latin America. npj Parkinson\u2019s Disease. https:\/\/doi.org\/10.1038\/s41531-022-00358-z","DOI":"10.1038\/s41531-022-00358-z"},{"key":"9427_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2023.101006","author":"M Basgalupp","year":"2023","unstructured":"Basgalupp M et al (2023) Frequency of GBA1 variants in Parkinson\u2019s disease patients from Southern Brazil. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101006","journal-title":"Parkinsonism Relat Disord"},{"key":"9427_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29614","author":"M Awad","year":"2023","unstructured":"Awad M et al (2023) GBA1 variants in Parkinson\u2019s disease: frequency and distribution in Latin American populations. Mov Disord. https:\/\/doi.org\/10.1002\/mds.29614","journal-title":"Mov Disord"},{"key":"9427_CR9","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2022.18.3.259","author":"HW Shin","year":"2022","unstructured":"Shin HW, Hong SW, Youn YC (2022) Clinical aspects of the differential diagnosis of Parkinson\u2019s disease and parkinsonism. J Clin Neurol. https:\/\/doi.org\/10.3988\/jcn.2022.18.3.259","journal-title":"J Clin Neurol"},{"key":"9427_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137102","author":"A Skrahin","year":"2024","unstructured":"Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G et al (2024) GBA1-associated Parkinson\u2019s disease is a distinct entity. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137102","journal-title":"Int J Mol Sci"},{"key":"9427_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000057","author":"G Lopez","year":"2016","unstructured":"Lopez G et al (2016) Clinical course and prognosis in patients with Gaucher disease and parkinsonism. Neurology: Genet. https:\/\/doi.org\/10.1212\/NXG.0000000000000057","journal-title":"Neurology: Genet"},{"key":"9427_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032044","author":"Z Granek","year":"2023","unstructured":"Granek Z, Barczuk J, Siwecka N, Rozp\u0119dek-Kami\u0144ska W, Kucharska E, Majsterek I (2023) GBA1 gene mutations in \u03b1-synucleinopathies\u2014molecular mechanisms underlying pathology and their clinical significance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032044","journal-title":"Int J Mol Sci"},{"issue":"12","key":"9427_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/genes15121605","volume":"15","author":"C Koros","year":"2024","unstructured":"Koros C, Bougea A, Alefanti I, Simitsi AM, Papagiannakis N, Pachi I et al (2024) A global perspective of GBA1-related Parkinson\u2019s disease: a narrative review. Genes (Basel) 15(12):1605. https:\/\/doi.org\/10.3390\/genes15121605","journal-title":"Genes (Basel)"},{"key":"9427_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"9427_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081261","author":"L Smith","year":"2022","unstructured":"Smith L, Schapira AHV (2022) GBA variants and Parkinson disease: mechanisms and treatments. Cells. https:\/\/doi.org\/10.3390\/cells11081261","journal-title":"Cells"},{"key":"9427_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2017.62","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"9427_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108419","author":"E Menozzi","year":"2023","unstructured":"Menozzi E, Toffoli M, Schapira AHV (2023) Targeting the GBA1 pathway to slow Parkinson disease: insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108419","journal-title":"Pharmacol Ther"},{"key":"9427_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.06.030","author":"C Noelker","year":"2015","unstructured":"Noelker C, Hauser AK, Bacher M, Gocke P, Riemenschneider MJ, Michel U et al (2015) Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2015.06.030","journal-title":"J Neurol Sci"},{"key":"9427_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00281-6","author":"SY-Y Pang","year":"2022","unstructured":"Pang SY-Y, Ho PW-L, Liu HF, Leung CT, Li L, Chang EES et al (2022) LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson\u2019s disease. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-022-00281-6","journal-title":"Transl Neurodegener"},{"key":"9427_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-017-0123-6","author":"L Cook","year":"2017","unstructured":"Cook L, Schulze J (2017) Connecting Gaucher and Parkinson disease: considerations for clinical and research genetic counseling settings. J Genet Couns. https:\/\/doi.org\/10.1007\/s10897-017-0123-6","journal-title":"J Genet Couns"},{"key":"9427_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107023","author":"M Marano","year":"2024","unstructured":"Marano M, Bernardi G, Raspanti B, Crivellaro M, Gentile G, Saccucci S et al (2024) Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson\u2019s disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107023","journal-title":"Parkinsonism Relat Disord"},{"key":"9427_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-017-0161-0","author":"M Mulhern","year":"2018","unstructured":"Mulhern M, Upadhyay A, DeLozier AM, Messner DA, Klein C, Shulman LM et al (2018) Patients\u2019 opinions on genetic counseling on the increased risk of Parkinson disease among Gaucher disease carriers. J Genet Couns. https:\/\/doi.org\/10.1007\/s10897-017-0161-0","journal-title":"J Genet Couns"},{"key":"9427_CR23","doi-asserted-by":"publisher","unstructured":"Alcalay RN, Mallett V, Vanderperre B, Ruskey JA, Fasano A et al (2020) Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genet Med. https:\/\/doi.org\/10.1038\/s41436-019-0684-x","DOI":"10.1038\/s41436-019-0684-x"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09427-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09427-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:07:53Z","timestamp":1790824073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09427-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9427"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09427-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was submitted to and approved by the Research Ethics Committee (CEP) involving Human Subjects of the Institute of Health Sciences, Federal University of Par\u00e1, under CAAE: 25162319.7.0000.0018 and opinion number 3.719.742. A detailed explanation of the study objectives was provided to the participant, and written informed consent was obtained prior to the collection of any biological material.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"827"}}